Eton Pharmaceuticals, Inc.ETONNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank25
3Y CAGR-27.2%
5Y CAGR-18.0%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
-27.2%/yr
Annual compound
5Y CAGR
-18.0%/yr
Recent deceleration
Percentile
P25
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
20250.10-74.5%
20240.39+130.9%
20230.17-34.7%
20220.26+6.9%
20210.24-10.2%
20200.27+1.6%
20190.27-
20180.00-
20170.00-